nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Ifosfamide—testicular cancer	0.165	0.259	CbGbCtD
Memantine—SLC22A2—Vinblastine—testicular cancer	0.11	0.172	CbGbCtD
Memantine—CYP2B6—Ifosfamide—testicular cancer	0.107	0.168	CbGbCtD
Memantine—SLC22A2—Cisplatin—testicular cancer	0.1	0.158	CbGbCtD
Memantine—CYP2C19—Ifosfamide—testicular cancer	0.0682	0.107	CbGbCtD
Memantine—CYP2B6—Cisplatin—testicular cancer	0.0522	0.0819	CbGbCtD
Memantine—CYP2B6—Doxorubicin—testicular cancer	0.035	0.0549	CbGbCtD
Memantine—Conjunctivitis—Doxorubicin—testicular cancer	0.00015	0.000414	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—testicular cancer	0.00015	0.000414	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—testicular cancer	0.00015	0.000413	CcSEcCtD
Memantine—Hepatitis—Epirubicin—testicular cancer	0.00015	0.000413	CcSEcCtD
Memantine—Eye disorder—Methotrexate—testicular cancer	0.00015	0.000413	CcSEcCtD
Memantine—Tinnitus—Methotrexate—testicular cancer	0.000149	0.000412	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—testicular cancer	0.000149	0.000411	CcSEcCtD
Memantine—Asthenia—Cisplatin—testicular cancer	0.000149	0.00041	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—testicular cancer	0.000149	0.00041	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—testicular cancer	0.000149	0.00041	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—testicular cancer	0.000148	0.000408	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—testicular cancer	0.000148	0.000407	CcSEcCtD
Memantine—Haematuria—Doxorubicin—testicular cancer	0.000147	0.000406	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—testicular cancer	0.000147	0.000406	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—testicular cancer	0.000147	0.000405	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000146	0.000403	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—testicular cancer	0.000146	0.000402	CcSEcCtD
Memantine—Angiopathy—Methotrexate—testicular cancer	0.000145	0.000401	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—testicular cancer	0.000145	0.0004	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—testicular cancer	0.000145	0.000399	CcSEcCtD
Memantine—Visual impairment—Epirubicin—testicular cancer	0.000144	0.000398	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—testicular cancer	0.000144	0.000398	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—testicular cancer	0.000144	0.000397	CcSEcCtD
Memantine—Chills—Methotrexate—testicular cancer	0.000144	0.000396	CcSEcCtD
Memantine—Nausea—Ifosfamide—testicular cancer	0.000143	0.000394	CcSEcCtD
Memantine—Diarrhoea—Cisplatin—testicular cancer	0.000142	0.000391	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—testicular cancer	0.000142	0.000391	CcSEcCtD
Memantine—Alopecia—Methotrexate—testicular cancer	0.000141	0.00039	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—testicular cancer	0.000141	0.000389	CcSEcCtD
Memantine—Mental disorder—Methotrexate—testicular cancer	0.00014	0.000387	CcSEcCtD
Memantine—Eye disorder—Epirubicin—testicular cancer	0.00014	0.000386	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—testicular cancer	0.00014	0.000386	CcSEcCtD
Memantine—Tinnitus—Epirubicin—testicular cancer	0.00014	0.000385	CcSEcCtD
Memantine—Malnutrition—Methotrexate—testicular cancer	0.000139	0.000384	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—testicular cancer	0.000139	0.000384	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—testicular cancer	0.000139	0.000383	CcSEcCtD
Memantine—Flushing—Epirubicin—testicular cancer	0.000139	0.000383	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—testicular cancer	0.000139	0.000383	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—testicular cancer	0.000139	0.000382	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—testicular cancer	0.000139	0.000382	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000138	0.00038	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—testicular cancer	0.000138	0.000379	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000137	0.000378	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—testicular cancer	0.000137	0.000377	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—testicular cancer	0.000136	0.000376	CcSEcCtD
Memantine—Asthenia—Etoposide—testicular cancer	0.000136	0.000376	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000136	0.000376	CcSEcCtD
Memantine—Angiopathy—Epirubicin—testicular cancer	0.000136	0.000375	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—testicular cancer	0.000136	0.000375	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—testicular cancer	0.000135	0.000373	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—testicular cancer	0.000135	0.000372	CcSEcCtD
Memantine—Back pain—Methotrexate—testicular cancer	0.000135	0.000372	CcSEcCtD
Memantine—Chills—Epirubicin—testicular cancer	0.000134	0.000371	CcSEcCtD
Memantine—Pruritus—Etoposide—testicular cancer	0.000134	0.000371	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—testicular cancer	0.000134	0.000369	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—testicular cancer	0.000134	0.000368	CcSEcCtD
Memantine—Alopecia—Epirubicin—testicular cancer	0.000132	0.000365	CcSEcCtD
Memantine—Vomiting—Cisplatin—testicular cancer	0.000132	0.000363	CcSEcCtD
Memantine—Vision blurred—Methotrexate—testicular cancer	0.000131	0.000362	CcSEcCtD
Memantine—Mental disorder—Epirubicin—testicular cancer	0.000131	0.000362	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—testicular cancer	0.000131	0.000361	CcSEcCtD
Memantine—Rash—Cisplatin—testicular cancer	0.000131	0.00036	CcSEcCtD
Memantine—Dermatitis—Cisplatin—testicular cancer	0.000131	0.00036	CcSEcCtD
Memantine—Malnutrition—Epirubicin—testicular cancer	0.00013	0.00036	CcSEcCtD
Memantine—Diarrhoea—Etoposide—testicular cancer	0.00013	0.000358	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—testicular cancer	0.00013	0.000357	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—testicular cancer	0.000129	0.000357	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—testicular cancer	0.000129	0.000356	CcSEcCtD
Memantine—Anaemia—Methotrexate—testicular cancer	0.000129	0.000355	CcSEcCtD
Memantine—Flushing—Doxorubicin—testicular cancer	0.000129	0.000355	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—testicular cancer	0.000129	0.000355	CcSEcCtD
Memantine—Flatulence—Epirubicin—testicular cancer	0.000129	0.000354	CcSEcCtD
Memantine—Tension—Epirubicin—testicular cancer	0.000128	0.000353	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—testicular cancer	0.000128	0.000352	CcSEcCtD
Memantine—Nervousness—Epirubicin—testicular cancer	0.000127	0.000349	CcSEcCtD
Memantine—Back pain—Epirubicin—testicular cancer	0.000126	0.000348	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—testicular cancer	0.000126	0.000347	CcSEcCtD
Memantine—Malaise—Methotrexate—testicular cancer	0.000126	0.000347	CcSEcCtD
Memantine—Dizziness—Etoposide—testicular cancer	0.000126	0.000346	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—testicular cancer	0.000125	0.000345	CcSEcCtD
Memantine—Vertigo—Methotrexate—testicular cancer	0.000125	0.000345	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000125	0.000345	CcSEcCtD
Memantine—Leukopenia—Methotrexate—testicular cancer	0.000125	0.000344	CcSEcCtD
Memantine—Chills—Doxorubicin—testicular cancer	0.000124	0.000343	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—testicular cancer	0.000124	0.000342	CcSEcCtD
Memantine—Nausea—Cisplatin—testicular cancer	0.000123	0.00034	CcSEcCtD
Memantine—Vision blurred—Epirubicin—testicular cancer	0.000123	0.000339	CcSEcCtD
Memantine—Alopecia—Doxorubicin—testicular cancer	0.000122	0.000338	CcSEcCtD
Memantine—Cough—Methotrexate—testicular cancer	0.000122	0.000335	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—testicular cancer	0.000121	0.000335	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—testicular cancer	0.000121	0.000334	CcSEcCtD
Memantine—Convulsion—Methotrexate—testicular cancer	0.000121	0.000333	CcSEcCtD
Memantine—Vomiting—Etoposide—testicular cancer	0.000121	0.000333	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—testicular cancer	0.000121	0.000333	CcSEcCtD
Memantine—Anaemia—Epirubicin—testicular cancer	0.000121	0.000332	CcSEcCtD
Memantine—Agitation—Epirubicin—testicular cancer	0.00012	0.000331	CcSEcCtD
Memantine—Rash—Etoposide—testicular cancer	0.00012	0.00033	CcSEcCtD
Memantine—Dermatitis—Etoposide—testicular cancer	0.00012	0.00033	CcSEcCtD
Memantine—Headache—Etoposide—testicular cancer	0.000119	0.000328	CcSEcCtD
Memantine—Flatulence—Doxorubicin—testicular cancer	0.000119	0.000328	CcSEcCtD
Memantine—Chest pain—Methotrexate—testicular cancer	0.000119	0.000327	CcSEcCtD
Memantine—Arthralgia—Methotrexate—testicular cancer	0.000119	0.000327	CcSEcCtD
Memantine—Myalgia—Methotrexate—testicular cancer	0.000119	0.000327	CcSEcCtD
Memantine—Tension—Doxorubicin—testicular cancer	0.000118	0.000327	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—testicular cancer	0.000118	0.000326	CcSEcCtD
Memantine—Malaise—Epirubicin—testicular cancer	0.000118	0.000324	CcSEcCtD
Memantine—Discomfort—Methotrexate—testicular cancer	0.000117	0.000323	CcSEcCtD
Memantine—Nervousness—Doxorubicin—testicular cancer	0.000117	0.000323	CcSEcCtD
Memantine—Vertigo—Epirubicin—testicular cancer	0.000117	0.000323	CcSEcCtD
Memantine—Syncope—Epirubicin—testicular cancer	0.000117	0.000323	CcSEcCtD
Memantine—Leukopenia—Epirubicin—testicular cancer	0.000117	0.000322	CcSEcCtD
Memantine—Back pain—Doxorubicin—testicular cancer	0.000117	0.000322	CcSEcCtD
Memantine—Palpitations—Epirubicin—testicular cancer	0.000115	0.000318	CcSEcCtD
Memantine—Confusional state—Methotrexate—testicular cancer	0.000115	0.000316	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—testicular cancer	0.000115	0.000316	CcSEcCtD
Memantine—Cough—Epirubicin—testicular cancer	0.000114	0.000314	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—testicular cancer	0.000114	0.000314	CcSEcCtD
Memantine—Convulsion—Epirubicin—testicular cancer	0.000113	0.000312	CcSEcCtD
Memantine—Infection—Methotrexate—testicular cancer	0.000113	0.000312	CcSEcCtD
Memantine—Nausea—Etoposide—testicular cancer	0.000113	0.000311	CcSEcCtD
Memantine—Hypertension—Epirubicin—testicular cancer	0.000113	0.000311	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000112	0.000309	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—testicular cancer	0.000112	0.000308	CcSEcCtD
Memantine—Anaemia—Doxorubicin—testicular cancer	0.000112	0.000308	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—testicular cancer	0.000111	0.000307	CcSEcCtD
Memantine—Arthralgia—Epirubicin—testicular cancer	0.000111	0.000306	CcSEcCtD
Memantine—Myalgia—Epirubicin—testicular cancer	0.000111	0.000306	CcSEcCtD
Memantine—Chest pain—Epirubicin—testicular cancer	0.000111	0.000306	CcSEcCtD
Memantine—Agitation—Doxorubicin—testicular cancer	0.000111	0.000306	CcSEcCtD
Memantine—Anxiety—Epirubicin—testicular cancer	0.000111	0.000305	CcSEcCtD
Memantine—Skin disorder—Methotrexate—testicular cancer	0.00011	0.000305	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—testicular cancer	0.00011	0.000303	CcSEcCtD
Memantine—Discomfort—Epirubicin—testicular cancer	0.00011	0.000303	CcSEcCtD
Memantine—Malaise—Doxorubicin—testicular cancer	0.000109	0.0003	CcSEcCtD
Memantine—Dry mouth—Epirubicin—testicular cancer	0.000109	0.000299	CcSEcCtD
Memantine—Vertigo—Doxorubicin—testicular cancer	0.000108	0.000299	CcSEcCtD
Memantine—Anorexia—Methotrexate—testicular cancer	0.000108	0.000299	CcSEcCtD
Memantine—Syncope—Doxorubicin—testicular cancer	0.000108	0.000298	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—testicular cancer	0.000108	0.000298	CcSEcCtD
Memantine—Confusional state—Epirubicin—testicular cancer	0.000107	0.000296	CcSEcCtD
Memantine—Palpitations—Doxorubicin—testicular cancer	0.000107	0.000294	CcSEcCtD
Memantine—Oedema—Epirubicin—testicular cancer	0.000106	0.000294	CcSEcCtD
Memantine—Hypotension—Methotrexate—testicular cancer	0.000106	0.000293	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—testicular cancer	0.000106	0.000293	CcSEcCtD
Memantine—Infection—Epirubicin—testicular cancer	0.000106	0.000292	CcSEcCtD
Memantine—Cough—Doxorubicin—testicular cancer	0.000105	0.00029	CcSEcCtD
Memantine—Shock—Epirubicin—testicular cancer	0.000105	0.000289	CcSEcCtD
Memantine—Convulsion—Doxorubicin—testicular cancer	0.000105	0.000288	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—testicular cancer	0.000104	0.000288	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—testicular cancer	0.000104	0.000287	CcSEcCtD
Memantine—Hypertension—Doxorubicin—testicular cancer	0.000104	0.000287	CcSEcCtD
Memantine—Tachycardia—Epirubicin—testicular cancer	0.000104	0.000287	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000104	0.000286	CcSEcCtD
Memantine—Skin disorder—Epirubicin—testicular cancer	0.000103	0.000285	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—testicular cancer	0.000103	0.000284	CcSEcCtD
Memantine—Insomnia—Methotrexate—testicular cancer	0.000103	0.000284	CcSEcCtD
Memantine—Chest pain—Doxorubicin—testicular cancer	0.000103	0.000283	CcSEcCtD
Memantine—Myalgia—Doxorubicin—testicular cancer	0.000103	0.000283	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—testicular cancer	0.000103	0.000283	CcSEcCtD
Memantine—Anxiety—Doxorubicin—testicular cancer	0.000102	0.000282	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—testicular cancer	0.000102	0.000282	CcSEcCtD
Memantine—Discomfort—Doxorubicin—testicular cancer	0.000102	0.00028	CcSEcCtD
Memantine—Anorexia—Epirubicin—testicular cancer	0.000101	0.00028	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—testicular cancer	0.000101	0.00028	CcSEcCtD
Memantine—Somnolence—Methotrexate—testicular cancer	0.000101	0.000279	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—testicular cancer	0.0001	0.000277	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—testicular cancer	0.0001	0.000276	CcSEcCtD
Memantine—Hypotension—Epirubicin—testicular cancer	9.95e-05	0.000274	CcSEcCtD
Memantine—Confusional state—Doxorubicin—testicular cancer	9.93e-05	0.000274	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—testicular cancer	9.89e-05	0.000273	CcSEcCtD
Memantine—Oedema—Doxorubicin—testicular cancer	9.85e-05	0.000272	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—testicular cancer	9.82e-05	0.000271	CcSEcCtD
Memantine—Fatigue—Methotrexate—testicular cancer	9.81e-05	0.00027	CcSEcCtD
Memantine—Infection—Doxorubicin—testicular cancer	9.78e-05	0.00027	CcSEcCtD
Memantine—Pain—Methotrexate—testicular cancer	9.73e-05	0.000268	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.7e-05	0.000267	CcSEcCtD
Memantine—Shock—Doxorubicin—testicular cancer	9.69e-05	0.000267	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—testicular cancer	9.66e-05	0.000266	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—testicular cancer	9.64e-05	0.000266	CcSEcCtD
Memantine—Insomnia—Epirubicin—testicular cancer	9.63e-05	0.000266	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—testicular cancer	9.61e-05	0.000265	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—testicular cancer	9.57e-05	0.000264	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—testicular cancer	9.56e-05	0.000264	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—testicular cancer	9.52e-05	0.000263	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—testicular cancer	9.49e-05	0.000262	CcSEcCtD
Memantine—Somnolence—Epirubicin—testicular cancer	9.46e-05	0.000261	CcSEcCtD
Memantine—Anorexia—Doxorubicin—testicular cancer	9.39e-05	0.000259	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—testicular cancer	9.37e-05	0.000259	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—testicular cancer	9.37e-05	0.000258	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—testicular cancer	9.3e-05	0.000257	CcSEcCtD
Memantine—Decreased appetite—Epirubicin—testicular cancer	9.25e-05	0.000255	CcSEcCtD
Memantine—Hypotension—Doxorubicin—testicular cancer	9.2e-05	0.000254	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—testicular cancer	9.19e-05	0.000253	CcSEcCtD
Memantine—Fatigue—Epirubicin—testicular cancer	9.18e-05	0.000253	CcSEcCtD
Memantine—Pain—Epirubicin—testicular cancer	9.1e-05	0.000251	CcSEcCtD
Memantine—Constipation—Epirubicin—testicular cancer	9.1e-05	0.000251	CcSEcCtD
Memantine—Urticaria—Methotrexate—testicular cancer	9.04e-05	0.000249	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—testicular cancer	8.99e-05	0.000248	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—testicular cancer	8.99e-05	0.000248	CcSEcCtD
Memantine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.97e-05	0.000247	CcSEcCtD
Memantine—Insomnia—Doxorubicin—testicular cancer	8.91e-05	0.000246	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—testicular cancer	8.84e-05	0.000244	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—testicular cancer	8.78e-05	0.000242	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—testicular cancer	8.77e-05	0.000242	CcSEcCtD
Memantine—Somnolence—Doxorubicin—testicular cancer	8.76e-05	0.000241	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—testicular cancer	8.7e-05	0.00024	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—testicular cancer	8.67e-05	0.000239	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—testicular cancer	8.56e-05	0.000236	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.5e-05	0.000235	CcSEcCtD
Memantine—Fatigue—Doxorubicin—testicular cancer	8.49e-05	0.000234	CcSEcCtD
Memantine—Urticaria—Epirubicin—testicular cancer	8.46e-05	0.000233	CcSEcCtD
Memantine—Pain—Doxorubicin—testicular cancer	8.42e-05	0.000232	CcSEcCtD
Memantine—Constipation—Doxorubicin—testicular cancer	8.42e-05	0.000232	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—testicular cancer	8.41e-05	0.000232	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—testicular cancer	8.41e-05	0.000232	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—testicular cancer	8.38e-05	0.000231	CcSEcCtD
Memantine—Asthenia—Methotrexate—testicular cancer	8.16e-05	0.000225	CcSEcCtD
Memantine—Feeling abnormal—Doxorubicin—testicular cancer	8.12e-05	0.000224	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—testicular cancer	8.05e-05	0.000222	CcSEcCtD
Memantine—Pruritus—Methotrexate—testicular cancer	8.05e-05	0.000222	CcSEcCtD
Memantine—Hypersensitivity—Epirubicin—testicular cancer	7.84e-05	0.000216	CcSEcCtD
Memantine—Urticaria—Doxorubicin—testicular cancer	7.82e-05	0.000216	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—testicular cancer	7.79e-05	0.000215	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—testicular cancer	7.79e-05	0.000215	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—testicular cancer	7.78e-05	0.000215	CcSEcCtD
Memantine—Asthenia—Epirubicin—testicular cancer	7.64e-05	0.000211	CcSEcCtD
Memantine—Pruritus—Epirubicin—testicular cancer	7.53e-05	0.000208	CcSEcCtD
Memantine—Dizziness—Methotrexate—testicular cancer	7.52e-05	0.000207	CcSEcCtD
Memantine—Diarrhoea—Epirubicin—testicular cancer	7.28e-05	0.000201	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—testicular cancer	7.26e-05	0.0002	CcSEcCtD
Memantine—Vomiting—Methotrexate—testicular cancer	7.23e-05	0.000199	CcSEcCtD
Memantine—Rash—Methotrexate—testicular cancer	7.17e-05	0.000198	CcSEcCtD
Memantine—Dermatitis—Methotrexate—testicular cancer	7.16e-05	0.000198	CcSEcCtD
Memantine—Headache—Methotrexate—testicular cancer	7.13e-05	0.000197	CcSEcCtD
Memantine—Asthenia—Doxorubicin—testicular cancer	7.07e-05	0.000195	CcSEcCtD
Memantine—Dizziness—Epirubicin—testicular cancer	7.04e-05	0.000194	CcSEcCtD
Memantine—Pruritus—Doxorubicin—testicular cancer	6.97e-05	0.000192	CcSEcCtD
Memantine—Vomiting—Epirubicin—testicular cancer	6.77e-05	0.000187	CcSEcCtD
Memantine—Nausea—Methotrexate—testicular cancer	6.76e-05	0.000186	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—testicular cancer	6.74e-05	0.000186	CcSEcCtD
Memantine—Rash—Epirubicin—testicular cancer	6.71e-05	0.000185	CcSEcCtD
Memantine—Dermatitis—Epirubicin—testicular cancer	6.7e-05	0.000185	CcSEcCtD
Memantine—Headache—Epirubicin—testicular cancer	6.67e-05	0.000184	CcSEcCtD
Memantine—Dizziness—Doxorubicin—testicular cancer	6.51e-05	0.00018	CcSEcCtD
Memantine—Nausea—Epirubicin—testicular cancer	6.32e-05	0.000174	CcSEcCtD
Memantine—Vomiting—Doxorubicin—testicular cancer	6.26e-05	0.000173	CcSEcCtD
Memantine—Rash—Doxorubicin—testicular cancer	6.21e-05	0.000171	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—testicular cancer	6.2e-05	0.000171	CcSEcCtD
Memantine—Headache—Doxorubicin—testicular cancer	6.17e-05	0.00017	CcSEcCtD
Memantine—Nausea—Doxorubicin—testicular cancer	5.85e-05	0.000161	CcSEcCtD
